Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.
Six months of haloperidol treatment significantly increased the serum sulfhydryl (SH) levels in all 12 rheumatoid arthritis (RA) patients studied and significantly decreased the PIP joints technetium index (Tc-index), erythrocyte sedimentation rate (ESR) and joint count. These findings suggest a specific antirheumatic activity of haloperidol in the RA patients.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012701:Serotonin / Q000097:blood; D013438:Sulfhydryl Compounds / Q000097:blood*; D013667:Technetium
D013438:Sulfhydryl Compounds; D012701:Serotonin; D013667:Technetium; D006220:Haloperidol